NCT01838798

Brief Summary

This is a prospective, single-center, pilot, cohort study. The first phase of this study is observational and the usual care of patients is maintained during the ICU stay, except for an interview with a psychologist preceding patient discharge. A phone interview at 2 months and a visit with a psychologist at four months after ICU discharge are specific to the study. The main objective of this study is to make a first estimate of the percentage of patients (CI = +- 10%) with cognitive impairment at four months after ICU discharge. The presence / absence of cognitive impairment will be determined by the D2 test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 21, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 24, 2013

Completed
6 months until next milestone

Study Start

First participant enrolled

November 1, 2013

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

December 19, 2025

Status Verified

October 1, 2016

Enrollment Period

2.9 years

First QC Date

April 21, 2013

Last Update Submit

December 15, 2025

Conditions

Keywords

cognitive disordersquality of lifeIntensive care

Outcome Measures

Primary Outcomes (1)

  • Presence/absence of cognitive impairment

    based on D2 test

    4 months after ICU discharge

Secondary Outcomes (23)

  • Duration of sedation

    expected average of 48 hours

  • Duration of ventilation

    expected average of 36 hours

  • Daily average for RASS scale

    Expected maximum of 28 days

  • Daily average for Behaviour pain scale

    expected average of 48 hours

  • CAM ICU score

    upon awakening (expected average of 48 hours)

  • +18 more secondary outcomes

Study Arms (1)

Study population

EXPERIMENTAL

See in inclusion/exclusion criteria. Interventions: Baseline activities; Clinical interview with a psychologist; Telephone interview 2 months after ICU discharge; Clinical interview with a psychologist .

Other: Baseline activitiesOther: Clinical interview with a psychologistOther: Telephone interview 2 months after ICU discharge

Interventions

Initial consent procedures and baseline data collection.

Study population

Clinical interview with a psychologist. This interview with a psychologist will take place after patient consent procedures, and at least 2 days after discontinuation of sedation, and before leaving the ICU. This interview will include: * An inventory of peritraumatic distress symptoms * A questionnaire on peritraumatic dissociative experiences * An assessment of related, potential impacts * The HADS questionnaire

Study population

At 2 months after leaving the ICU, a psychologist will contact the patient with questions regarding his/her representation of hospitalization. This implies the following: * Questionnaires assessing memories and stressors (Questionnaires ICUMT, and ICU-SEQ * An assessment of psychological trauma * An assessment of potential impacts

Study population

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient (or his/her "trusted person") must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for a telephone interview at 2 months after ICU discharge, and for a follow-up visit at 4 months after ICU discharge
  • Patient admitted to the ICU and intubated and ventilated for at least 48 hours

You may not qualify if:

  • The patient is currently participating in or has participated in another study (within the past 3 months) that might influence the results of the current study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient is pregnant, parturient, or breastfeeding
  • The patient has a contra-indication for a treatment used in this study
  • Patient admitted to intensive care with sedation started for more than 24 hours
  • Patient with neurological or psychiatric (cognitive) disorders
  • Patient admitted for cardiac arrest
  • Patient admitted for stroke
  • Patient admitted for cervical trauma \> C6
  • Patient presenting with tracheotomy accompanied by long-term mechanical ventilation
  • Moribund patient or with little hope of survival beyond 48 hours
  • Patients for whom a limitation or termination of care is considered
  • McCabe Score = 0
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, 30029, France

Location

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticDepressionCognitive Dysfunction

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersBehavioral SymptomsBehaviorCognition DisordersNeurocognitive Disorders

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Justine Pereira

    Centre Hospitalier Universitaire de Nîmes

    STUDY DIRECTOR
  • Claire Roger, MD

    Centre Hospitalier Universitaire de Nîmes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2013

First Posted

April 24, 2013

Study Start

November 1, 2013

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

December 19, 2025

Record last verified: 2016-10

Locations